Intrathecal medication delivery

Neurosurgery Clinics of North America

Volumn 14, Issue 3, 2003, Pages 381-387

  Penn, Richard D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; BUPIVACAINE; CLONIDINE; DIURETIC AGENT; HYDROMORPHONE; MORPHINE;

AMENORRHEA; CANCER PAIN; CATHETER; CEREBROSPINAL FLUID; DIAPHORESIS; DROWSINESS; DRUG DELIVERY SYSTEM; HUMAN; IMPOTENCE; LIBIDO DISORDER; MYOCLONUS; NAUSEA; NEUROENDOCRINE DISEASE; NEUROPATHIC PAIN; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; SPINAL CORD; VOMITING; WEIGHT GAIN;

EID: 0037696034     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(03)00016-0     Document Type: Review

References (12)

1. Dougherty PM, Staats PS. Intrathecal drug therapy for chronic pain. From basic science to clinical practice. Anesthesiology 1999;91:1891-918.
2. Kroin JS, Ali A, York M, Penn RD. The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 1993;33:226-30.
3. Nicholson C, Syková E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci 1998;21:207-15.
4. Winkelmüller W, Burchiel K, Van Buyten J-P. Intrathecal opioid therapy for pain: efficacy and outcomes. Neuromodulation 1999;2:67-76.
5. Bennett G, Serafini M, Kurchiel K, et al. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000;20(suppl):S12-36.
6. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity and survival. J Clin Oncol 2002;20:4040-9.
7. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-80.
8. Bennett G, Burcheil K, Buchser E, et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage 2000;20(suppl):S37-43.
9. Gay MLF. Spinal morphine in nonmalignant chronic pain: a retrospective study in 39 patients. Neuromodulation 2002;5:150-9.
10. Winkelmüller M, Winkelmüller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-67.
11. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage 1994;9:126-31.
12. Coffey RJ, Burchief K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 2002;50:1-9.